Sue began her career as a UK hospital pharmacist, managing formularies and developing an early appreciation for how healthcare decisions are made when resources are constrained. She later spent 15 years at AstraZeneca in global roles spanning pricing, market access, and early evidence planning, gaining experience during a period when health technology assessment and global‑to‑local alignment were reshaping the pharmaceutical landscape. These experiences shaped her belief that value must be built in from the outset of all development and commercialization decisions
At Prime, Sue focuses on creating strong connections between evidence generation, payer insight, clinical development and commercial strategy. Her role includes guiding teams across the US and Europe and aligning senior leaders in HEOR, RWE, US market access and global access. She works closely with colleagues across Prime’s capabilities to ensure clients have clear, actionable strategies grounded in robust, relevant evidence.